patent

Thai government sets aside patent law to produce generic AIDS, heart disease drugs

Thursday, February 08, 2007 by: M.T. Whitney
Tags: drug patents, Thailand, AIDS drugs

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Biologist explains how marijuana causes tumor cells to commit suicide
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
Companies begin planting microchips under employees' skin
NJ cops bust teenagers shoveling snow without a permit
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
Chemotherapy kills cancer patients faster than no treatment at all
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
Why flu shots are the greatest medical fraud in history
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Flu vaccine kills 13 in Italy; death toll rises
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet

Delicious
(NaturalNews) Thailand has authorized compulsory licenses to produce generic versions of two patented drugs, one being a HIV/AIDS antiretroviral drug, breaking the patents held by drug companies.

The decision comes at the protest of the World Health Organization, which wanted the country to come to a compromise solution with the drug companies to negotiate lower prices.

The WHO also has concerns that government-produced generics will not be of the same quality or effectiveness compared to the patented drugs.

The drugs involved are Kaletra, an HIV/AIDS antiretroviral drug produced by Abbott Laboratories from Illinois, and the blood-thinning medication Plavix, a popular drug produced by Bristol-Meyers Squibb. Thailand's distribution of licenses to make the drugs is permitted by World Trade Organization rules, which say the country can declare a "national emergency" to produce the drugs and override held patents.

Thailand's breaking of the local patent on Kaletra comes four months after the country broke the patent on another HIV/AIDS drug, Efavirenz by Merck.

Among its population of 64 million people, Thailand has more than 580,000 people living with HIV/AIDS, and its national health care system attempts to treat more than 82,000 HIV-positive people.

The move to make generics is expected to save the government $24 million in costs: Treating a person using Kaletra costs the government more than $4,000 a year, whereas using a generic would cost an estimated $1,400 a year, meaning the comparative cost of using a generic is up to two-thirds less.

Kaletra is used in Thailand for patients whose HIV has overpowered a weaker government-produced drug given to them as a first line of defense. Plavix, the other drug that Thailand broke the patent for, is one of the top five drugs sold worldwide, with sales of nearly $6 billion in 2005 alone.

Breaking patents and licensing these generic drugs could improve the Thai government's ability to negotiate lower drug prices with pharmaceutical companies, the director of the Thailand-based Aids Access Foundation, Nimit Tien-udom, was reported as saying by the Thai News Agency.

Thailand is not the only country to break patents: India and Brazil are examples of other countries that produce generic versions of patented drugs under the "national emergency" regulations of the WTO.

A Canadian company also produced a generic version of Kaletra briefly in 2006 for the worldwide market until it was forced to stop.

###

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.